BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/16/2014 6:10:00 PM | Browse: 1671 | Download: 436
 |
Received |
|
2012-08-19 21:16 |
 |
Peer-Review Started |
|
2012-08-22 10:23 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
|
 |
Revised |
|
|
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2012-10-30 09:28 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2012-10-30 13:13 |
 |
Articles in Press |
|
|
 |
Edit the Manuscript by Language Editor |
|
2013-01-18 17:42 |
 |
Typeset the Manuscript |
|
2013-02-02 13:41 |
 |
Publish the Manuscript Online |
|
2013-02-18 09:31 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Autobiography |
| Article Title |
Successful balloon-occluded retrograde transvenous obliteration for bleeding duodenal varices using cyanoacrylate
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Rintaro Hashimoto, Keitaro Sofue, Yoshito Takeuchi, Kentaro Shibamoto and Yasuaki Arai |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Keitaro Sofue, MD, Department of Diagnostic Radiology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. keitarosofue@yahoo.co.jp
|
| Key Words |
Bleeding duodenal varices; Balloon-occluded retrograde transvenous obliteration; Cyanoacrylate; Combination therapy; Temporary portal vein occlusion |
| Core Tip |
|
| Publish Date |
2013-02-18 09:31 |
| Citation |
Hashimoto R, Sofue K, Takeuchi Y, Shibamoto K, Arai Y. Successful balloon-occluded retrograde transvenous obliteration for bleeding duodenal varices using cyanoacrylate. World J Gastroenterol 2013; 19(6): 951-954 |
| URL |
http://www.wjgnet.com/1007-9327/full/v19/i6/951.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v19.i6.951 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.